Activation of invariant natural killer T cells impedes liver regeneration by way of both IFN-γ- and IL-4-dependent mechanisms

Hepatology

Volumn 60, Issue 4, 2014, Pages 1356-1366

  Yin, Shi ^a,b   Wang, Hua ^a,b   Bertola, Adeline ^a   Feng, Dechun ^a   Xu, Ming Jiang ^a   Wang, Yan ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; PROTEIN BCL 2; STAT1 PROTEIN; STAT6 PROTEIN; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; ALPHA-GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD1D ANTIGEN, MOUSE; GALACTOSYLCERAMIDE; STAT6 PROTEIN, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL EXPANSION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWNSTREAM PROCESSING; GENE DISRUPTION; IN VITRO STUDY; INVARIANT NATURAL KILLER T CELL; LIVER CELL; LIVER REGENERATION; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PARTIAL HEPATECTOMY; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; LIVER; LIVER RESECTION; PATHOLOGY; PHYSIOLOGY; SURGERY;

ANIMALS; ANTIGENS, CD1D; CELL PROLIFERATION; GALACTOSYLCERAMIDES; HEPATECTOMY; HEPATOCYTES; IN VITRO TECHNIQUES; INTERFERON-GAMMA; INTERLEUKIN-4; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; NATURAL KILLER T-CELLS; STAT6 TRANSCRIPTION FACTOR;

EID: 84927714348     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27128     Document Type: Article

References (31)

1. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010;176:2-13.
2. Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol 2013;3:485-513.
3. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol 2012;57:692-694.
4. Fausto N. Involvement of the innate immune system in liver regeneration and injury. J Hepatol 2006;45:347-349.
5. Van Sweringen HL, Sakai N, Tevar AD, Burns JM, Edwards MJ, Lentsch AB. CXC chemokine signaling in the liver: impact on repair and regeneration. Hepatology 2011;54:1445-1453.
6. Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009;86:513-528.
7. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004;127:1525-1539.
8. Graubardt N, Fahrner R, Trochsler M, Keogh A, Breu K, Furer C, et al. Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysis. Hepatology 2013;57:1969-1979.
9. Besnard A, Julien B, Gonzales E, Tordjmann T. Innate immunity, purinergic system, and liver regeneration: a trip in complexity. Hepatology 2013;57:1688-1690.
10. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-568.
11. Gao B, Wang H, Lafdil F, Feng D. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol 2012;57:430-441.
12. Horras CJ, Lamb CL, Mitchell KA. Regulation of hepatocyte fate by interferon-gamma. Cytokine Growth Factor Rev 2011;22:35-43.
13. Kuperman DA, Schleimer RP. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr Mol Med 2008;8:384-392.
14. Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmun Rev 2011;10:793-800.
15. Duwaerts CC, Gregory SH. Targeting the diverse immunological functions expressed by hepatic NKT cells. Expert Opin Ther Targets 2011;15:973-988.
16. Ito H, Ando K, Nakayama T, Taniguchi M, Ezaki T, Saito K, et al. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 2003;38:1116-1124.
17. Nakashima H, Inui T, Habu Y, Kinoshita M, Nagao S, Kawaguchi A, et al. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 2006;131:1573-1583.
18. Dong Z, Zhang J, Sun R, Wei H, Tian Z. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007;45:1400-1412.
19. Hosoya S, Ikejima K, Takeda K, Arai K, Ishikawa S, Yamagata H, et al. Innate immune responses involving NK and NKT cells promote liver regeneration after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol 2013;304:G293-G299.
20. Sun R, Park O, Horiguchi N, Kulkarni S, Jeong WI, Sun HY, et al. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology 2006;44:955-966.
21. Wang H, Park O, Lafdil F, Shen K, Horiguchi N, Yin S, et al. Interplay of hepatic and myeloid STAT3 in facilitating liver regeneration via tempering innate immunity. Hepatology 2010;51:1354-1362.
22. Martin-Murphy BV, Kominsky DJ, Orlicky DJ, Donohue TM Jr, Ju C. Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury. Hepatology 2013;57:1575-1584.
23. Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, et al. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo. Immunol Lett 2004;95:5-11.
24. Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H, et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 2000;31:907-915.
25. DeAngelis RA, Markiewski MM, Kourtzelis I, Rafail S, Syriga M, Sandor A, et al. A complement-IL-4 regulatory circuit controls liver regeneration. J Immunol 2012;188:641-648.
26. Goh YP, Henderson NC, Heredia JE, Red Eagle A, Odegaard JI, Lehwald N, et al. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A 2013;110:9914-9919.
27. Wang H, Feng D, Park O, Yin S, Gao B. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: oppositely regulated by IL-4 and IFN-gamma. Hepatology 2013;58:1474-1485.
28. Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 2002;110:1503-1513.
29. Schneiders FL, Scheper RJ, von Blomberg BM, Woltman AM, Janssen HL, van den Eertwegh AJ, et al. Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clin Immunol 2011;140:130-141.
30. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192:921-930.
31. Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Sakamori R, Ohkawa K, et al. Intrahepatic delivery of alpha-galactosylceramide-pulsed dendritic cells suppresses liver tumor. Hepatology 2007;45:22-30.